(Litopenaeus vannamei): A Pilot Protocol for Ecuador
Versión en Español
Análisis Comparativo de Variantes de Quitosano para la Prevención de Melanosis en Camarón Blanco del Pacífico (Litopenaeus vannamei): Un Protocolo Piloto para Ecuador
1. Abstract
Melanosis (black spot) significantly degrades the commercial value of harvested Pacific white shrimp (Litopenaeus vannamei). Conventional treatments rely heavily on sodium metabisulfite (SMS) and 4-hexylresorcinol (4-HR), both of which face increasing regulatory scrutiny due to allergenicity and potential toxicity. This technical paper presents a comprehensive, evidence-based comparative protocol for shrimp producers in Ecuador. It evaluates three advanced chitosan derivatives—Carboxymethyl Chitosan (CMCS), Chitosan Oligosaccharide-Hydrochloride (COS-HCl), and Chitosan Oligosaccharide-Lactate (COS-Lac)—as clean-label alternatives. A 9-arm experimental protocol is established, utilizing qualitative evidence matrices and literature-supported outcomes to guide laboratory and pilot-scale implementation.
Versión en Español – ResumenLa melanosis (mancha negra) degrada significativamente el valor comercial del camarón blanco del Pacífico (Litopenaeus vannamei) cosechado. Los tratamientos convencionales dependen en gran medida del metabisulfito de sodio (SMS) y del 4-hexilresorcinol (4-HR), los cuales enfrentan un escrutinio regulatorio cada vez mayor debido a la alergenicidad y toxicidad potencial. Este documento técnico presenta un protocolo comparativo integral y basado en evidencia para productores de camarón en Ecuador. Evalúa tres derivados avanzados de quitosano —Quitosano Carboximetilado (CMCS), Oligosacárido de Quitosano-Clorhidrato (COS-HCl) y Oligosacárido de Quitosano-Lactato (COS-Lac)— como alternativas de etiqueta limpia. Se establece un protocolo experimental de 9 brazos, utilizando matrices de evidencia cualitativa y resultados respaldados por la literatura para guiar la implementación a escala de laboratorio y piloto.
2. Introduction
In the Ecuadorian shrimp industry, post-harvest quality preservation is critical for global export competitiveness. Melanosis is triggered by the polyphenol oxidase (PPO) enzyme system, which oxidizes phenols into quinones, eventually polymerizing into dark melanin pigments. While SMS is the traditional industry standard, its residues pose severe allergenic risks. 4-HR is highly effective but faces strict EU residue limits (2 mg/kg) due to risks of nephrotoxicity. Chitosan, a biopolymer derived from chitin, has emerged as a Generally Recognized as Safe (GRAS) alternative. However, standard chitosan suffers from poor aqueous solubility. This protocol compares three highly soluble, functionalized chitosan variants tailored for industrial dipping applications.
Versión en Español – IntroducciónEn la industria camaronera ecuatoriana, la preservación de la calidad poscosecha es fundamental para la competitividad en las exportaciones globales. La melanosis es desencadenada por el sistema enzimático polifenol oxidasa (PPO), que oxida los fenoles en quinonas, polimerizándose eventualmente en pigmentos oscuros de melanina. Aunque el SMS es el estándar tradicional de la industria, sus residuos plantean graves riesgos alergénicos. El 4-HR es altamente efectivo pero enfrenta estrictos límites de residuos en la UE (2 mg/kg) debido a riesgos de nefrotoxicidad. El quitosano, un biopolímero derivado de la quitina, ha surgido como una alternativa Generalmente Reconocida como Segura (GRAS). Sin embargo, el quitosano estándar adolece de mala solubilidad acuosa. Este protocolo compara tres variantes de quitosano funcionalizadas y altamente solubles, diseñadas para aplicaciones de inmersión industrial.
3. Physicochemical Comparison of Chitosan Variants
| Parameter | CMCS (Carboxymethyl Chitosan) | COS-HCl (Hydrochloride) | COS-Lac (Lactate) |
|---|---|---|---|
| Molecular Weight | High (Forms viscous gels/films) | Low (3 kDa) | Low (3 kDa) |
| Deacetylation (DDA) | High (>90%) | 98% | 98% |
| Zeta Potential (Charge) | Neutral / Negative (Amphoteric) | +70 mV (High positive) | +60 mV (Moderate positive) |
| Aqueous Solubility | Excellent (Broad pH range) | Excellent (Rapid dissolution) | Excellent (Rapid dissolution) |
| Primary Application | Edible coatings, drug delivery | Agriculture, strong antimicrobial | Food matrices, beverages |
| Food-Grade Status | Yes | Agriculture/Industrial (Agri-grade) | Yes (Food-grade) |
Versión en Español – Comparación FisicoquímicaLa tabla anterior compara los tres derivados. El CMCS es ideal para formar películas protectoras debido a su alto peso molecular. El COS-HCl posee una alta carga positiva (+70 mV) ideal para disrupción microbiana, aunque a menudo se clasifica para uso agrícola. El COS-Lac (+60 mV) está específicamente diseñado y certificado para matrices alimentarias, manteniendo una excelente solubilidad y capacidad antimicrobiana.
4. Evidence Summary Matrix
The following qualitative matrix evaluates the current strength of scientific evidence for each intervention specifically regarding shrimp melanosis prevention. Scale: ●●●●● (Very Strong) to ○○○○○ (None).
| Intervention | Direct Evidence in Shrimp | PPO Inhibition Evidence | Antimicrobial Efficacy | Overall Recommendation Level |
|---|---|---|---|---|
| SMS / Sulfites | ●●●●● | ●●●●● | ●●●○○ | Industry Baseline (Phase-out target) |
| 4-HR (0.1%) | ●●●●● | ●●●●● | ●●○○○ | Strong (Caution: Toxicity limits) |
| CMCS (Coatings) | ●●●●○ | ●●●○○ | ●●●●○ | High (Best film-former) |
| COS-Lac (+60mV) | ●●●○○ | ●●●○○ | ●●●●○ | Moderate-High (Food-safe alternative) |
| COS-HCl (+70mV) | ●●○○○ | ●●○○○ | ●●●●● | Moderate (Inferred from agri-data) |
| COS + 4-HR Synergy | ●●●●● | ●●●●● | ●●●●● | Highest (Optimal Tier 1 approach) |
Versión en Español – Matriz de Resumen de EvidenciaEsta matriz evalúa la fuerza de la evidencia científica actual. Los sulfitos y el 4-HR tienen evidencia directa muy fuerte (●●●●●), pero enfrentan presiones regulatorias. El CMCS tiene fuerte evidencia (●●●●○) como recubrimiento. La variante COS-Lac tiene evidencia moderada-alta para uso alimentario, mientras que COS-HCl se infiere principalmente de datos agrícolas. Las terapias combinadas (Sinergia COS + 4-HR) presentan la evidencia más fuerte y completa.
5. Mechanism of Action Comparison
| Variant | Primary Anti-Melanosis Mechanism | Secondary Benefits |
|---|---|---|
| CMCS | Forms a dense physical oxygen barrier over the carapace, denying oxygen to the PPO enzyme system. | Chelates copper ions required by tyrosinase; provides a stable matrix for other active agents (e.g., essential oils). |
| COS-HCl | High electrostatic interference (+70mV) disrupts microbial cell membranes, eliminating spoilage bacteria that accelerate degradation. | Strong free radical scavenging (donates protons from amino/hydroxyl groups) neutralizing reactive oxygen species. |
| COS-Lac | Penetrates tissue rapidly due to low MW (3 kDa); balances PPO enzyme chelation with strong antioxidant defense. | Activates internal antioxidant pathways (Keap-1/Nrf-2/HO-1); highly compatible with food processing environments. |
Versión en Español – Mecanismo de AcciónEl CMCS actúa principalmente como una barrera física contra el oxígeno y quelante de metales. El COS-HCl (+70mV) proporciona una fuerte disrupción antimicrobiana y eliminación de radicales libres. El COS-Lac (+60mV) ofrece una rápida penetración en el tejido, equilibrando la inhibición de PPO con una alta compatibilidad alimentaria.
6. Literature-Supported Outcomes
The following data points are extracted strictly from peer-reviewed studies to provide realistic benchmarks for the pilot trial.
| Study Reference | Treatment Parameters | Key Quantitative Findings (Actual Data) |
|---|---|---|
| IJA 2023 (Deep-water shrimp) | 0.5% HDD and LDD chitosan vs 1.54% SMS. Immersion 1:1.5 (v/w) at 4°C. | Day 12 melanosis area: 0.30% (HDD), 0.02% (LDD), vs 1.54% (SMS) and 4.01% (Citric acid). |
| PMC12014517 (CMCS study) | 1% CMCS + 2% pectin + 2% MP EO. 1 min dip, 1:2 ratio, 0°C ice storage. | Day 12: TVB-N 30.33 mg/100g, pH 7.04, TMB 6.87 log CFU/g, 75% PPO inhibition. |
| e-FAS 2022 (Hypotaurine synergy) | 1% chitosan + 2% hypotaurine. 30 min soak at 4°C, 1:2 ratio. | Day 10: Melanosis score 3.6 (vs 4.5 chitosan alone, 7.2 control). TVC 5.25 Log CFU/g. |
| PMC6859178 (RSM Optimization) | 1.36% chitosan + 0.47% citric acid + 0.31% L-cysteine. 5 min dip, 1:2 ratio. | Optimized formula effectively retarded ΔE color change and melanosis over 8 days. |
| SOP Document (Combination) | 0.05-0.1% 4-HR + 1-2% COS. 10-15 min at 4°C. 1:2 ratio. | Target shelf life 14-16 days. 4-HR residue kept <2 mg/kg. |
Versión en Español – Resultados Respaldados por la LiteraturaLa tabla superior resume datos reales de estudios citados. Por ejemplo, IJA 2023 demostró que el quitosano redujo el área de melanosis al 0.02-0.30% en el día 12, superando al SMS (1.54%). El estudio PMC12014517 logró un 75% de inhibición de PPO usando una matriz de CMCS al 1%. Estos valores sirven como línea base cuantitativa para los ensayos en Ecuador.
7. Comparative Protocol for Ecuador Lab (9-Treatment Arms)
To accurately assess efficacy, the pilot should divide fresh Litopenaeus vannamei into 9 specific treatment groups.
| Group | Formulation | Rationale |
|---|---|---|
| T0 | Water (Control) | Baseline for natural decay rate. |
| T1 | SMS 1.25% | Traditional industry standard benchmark. |
| T2 | 4-HR 0.1% | Modern chemical benchmark (adhering to EU limits). |
| T3 | CMCS 1.0% | Evaluation of high-MW physical film barrier. |
| T4 | COS-HCl 1.0% (+70mV) | Evaluation of high-charge agricultural variant. |
| T5 | COS-Lac 1.0% (+60mV) | Evaluation of food-grade low-MW variant. |
| T6 | CMCS 1.0% + 4-HR 0.1% | Synergy: Physical barrier + enzyme inhibition. |
| T7 | COS-Lac 1.0% + 4-HR 0.1% | SOP Protocol: Deep penetration + enzyme inhibition. |
| T8 | CMCS 1.36% + Citric 0.47% + L-cys 0.31% | Optimized 100% clean-label formulation (PMC6859178). |
Versión en Español – Protocolo Comparativo (9 Brazos)Para evaluar con precisión la eficacia en laboratorios de Ecuador, la prueba debe dividir el camarón en 9 grupos. Estos incluyen controles de agua (T0), estándares de la industria como SMS (T1) y 4-HR (T2), las tres variantes de quitosano puras (T3-T5), combinaciones sinérgicas de quitosano con 4-HR (T6-T7), y una fórmula 100% de etiqueta limpia optimizada con ácido cítrico y L-cisteína (T8).
8. Full SOP Protocol for Implementation
All parameters below are aligned with conditions reported in cited peer-reviewed literature to ensure replicability and comparability of results across treatment groups.
| Step | Parameter | Specification | Source Reference |
|---|---|---|---|
| 1 | Solution Preparation | Dissolve active ingredients in potable water. For CMCS, allow 4–6 h hydration. Chill all solutions to 4°C before use. | PMC12014517; PMC6859178 |
| 2 | Immersion Ratio | 1:2 ratio, weight of shrimp to volume of solution (w/v). | PMC12014517; e-FAS 2022; PMC6859178; SOP Document |
| 3a | Dipping Time — T3, T6 (CMCS film-forming) | 1 minute at 4°C with gentle agitation. | PMC12014517 |
| 3b | Dipping Time — T4, T5, T7 (COS variants, with 4-HR) | 10 to 15 minutes at 4°C with gentle agitation. | SOP Document; MDPI Foods 12(9):1763 |
| 3c | Dipping Time — T8 (Citric acid + L-cysteine blend) | 5 minutes at 4°C. | PMC6859178 |
| 3d | Dipping Time — T0, T1 (Control, SMS) | 10 to 15 minutes at 4°C to standardize exposure conditions. | e-FAS 2022; SOP Document |
| 4 | Drainage | Remove shrimp and drain on sanitized mesh for 5 to 10 minutes at ambient temperature (~20°C) to allow films to set. | PMC12014517; SOP Document |
| 5 | Packaging | Seal in sterile polyethylene bags (minimum 3 shrimp per replicate). | PMC12014517; e-FAS 2022 |
| 6 | Storage | Store in insulated boxes with 1:2 (shrimp-to-ice) ratio; maintain 0–4°C throughout trial. | PMC12014517; IJA 2023 |
| 7 | Replications | Minimum 3 replicates per treatment group. All analyses performed in triplicate. | e-FAS 2022; PMC6924340 |
| 8 | Sampling Schedule | Destructive sampling on Days 0, 3, 6, 9, 12, and 15. | PMC12014517; IJA 2023 |
Versión en Español — Procedimiento Operativo Estándar (SOP)Todos los parámetros están alineados con las condiciones reportadas en la literatura científica citada. Prepare las soluciones y enfíelas a 4°C. Use una proporción de inmersión de 1:2 (camarón:solución). Los tiempos de inmersión varían: 1 min para CMCS (formación de película, T3 y T6), 10–15 min para variantes COS y combinaciones con 4-HR (T4, T5, T7), y 5 min para la mezcla T8 (ácido cítrico + L-cisteína). Drene de 5 a 10 minutos a ~20°C. Empaque en bolsas de polietileno estériles y almacene en hielo (proporción camarón:hielo 1:2) a 0–4°C. Use mínimo 3 réplicas por grupo y realice todos los análisis por triplicado. Realice muestreos destructivos los días 0, 3, 6, 9, 12 y 15.
9. Measurement Parameters
| Parameter | Methodology / Scale | Target Threshold |
|---|---|---|
| Melanosis Score | Otwell and Marshall Visual Scale (0-10) | Score < 5.0 indicates acceptable commercial quality. |
| PPO Activity | Spectrophotometric assay (Absorbance at 410 nm) | Maximized inhibition percentage relative to Day 0 control. |
| Color Metrics | Digital colorimeter (L*, a*, b*) & Whiteness Index | Maintenance of high L* (lightness) values. |
| Total Volatile Basic Nitrogen (TVB-N) | Semi-micro steam distillation | < 30 mg N / 100g. |
| Lipid Oxidation (TBA/TBARS) | Thiobarbituric acid reactive substances assay | < 2-3 mg MDA / kg. |
| Microbial Load (TVC) | Total Viable Count via aerobic plating | < 7.0 log CFU/g. |
| pH & Texture | pH meter & Texture Profile Analysis (Hardness) | pH < 7.5; retention of tissue elasticity. |
Versión en Español – Parámetros de MediciónLa evaluación debe incluir puntuación visual de melanosis (escala de Otwell-Marshall 0-10, donde <5.0 es aceptable), ensayos de actividad de PPO, colorimetría digital (L*a*b*), TVB-N para degradación de proteínas (<30 mg/100g), TBA para oxidación de lípidos, conteo microbiano total (TVC) y análisis de textura y pH.
10. Regulatory and Safety Matrix
| Compound | Regulatory Limit / Status | Safety & Allergen Considerations |
|---|---|---|
| SMS (Sulfites) | Strict limits vary by country (often < 100 ppm) | Severe allergen risk. Mandatory labeling required. |
| 4-Hexylresorcinol (4-HR) | EU Limit: 2 mg/kg in edible tissue. US: GRAS | Risk of nephrotoxicity at high doses; strict process control required. |
| Chitosan (Crustacean Source) | GRAS / Clean Label | Potential shellfish allergen declarations required in some markets. |
| Chitosan (Mushroom/BSF) | GRAS / Clean Label | Non-allergenic, vegan/eco-friendly. Highly preferred for EU export. |
Versión en Español – Matriz Regulatoria y de SeguridadEl uso de SMS requiere etiquetado obligatorio debido a alergias. El 4-HR tiene un límite estricto en la UE de 2 mg/kg debido a riesgos de nefrotoxicidad, requiriendo control preciso. El quitosano de origen crustáceo es GRAS pero puede requerir declaraciones de alérgenos. El quitosano de origen fúngico o de mosca soldado negra (BSF) es la opción ideal para exportación a la UE al ser no alergénico y de etiqueta limpia.
10b. Data Recording Template
The following table provides a standardized data recording structure for each treatment group on each sampling day. All units are as specified in Section 9.
| Day | Group | Melanosis (0–10) | L* Value | TVB-N (mg/100g) | TBA (mg MDA/kg) | TVC (log CFU/g) | pH | Notes |
|---|---|---|---|---|---|---|---|---|
| 0 | T0–T8 | ______ | ______ | ______ | ______ | ______ | ______ | |
| 3 | T0–T8 | ______ | ______ | ______ | ______ | ______ | ______ | |
| 6 | T0–T8 | ______ | ______ | ______ | ______ | ______ | ______ | |
| 9 | T0–T8 | ______ | ______ | ______ | ______ | ______ | ______ | |
| 12 | T0–T8 | ______ | ______ | ______ | ______ | ______ | ______ | |
| 15 | T0–T8 | ______ | ______ | ______ | ______ | ______ | ______ |
Versión en Español — Plantilla de Registro de DatosUse la tabla anterior para registrar los datos de cada grupo de tratamiento (T0–T8) en cada día de muestreo (0, 3, 6, 9, 12, 15). Registre: puntuación de melanosis (0–10), valor L*, TVB-N (mg/100g), TBA (mg MDA/kg), TVC (log UFC/g) y pH. Imprima una tabla por réplica y por día de muestreo.
11. Cost and Sourcing Guidelines
Based on bulk supply data from Chitosan Global, accurate budgeting for scale-up should consider origin source and variant. All prices are indicative FOB; contact suppliers directly for current quotes and Certificate of Analysis (CoA) documentation.
| Variant / Source | Origin | FOB Price (Indicative per kg) | Minimum Order / Scale |
|---|---|---|---|
| CMCS | Mushroom | $155–$254 / kg | 1 kg MOQ. Scales down at 100 kg+. Product page |
| CMCS | Shellfish | $178–$222 / kg | 1 kg MOQ. Food Grade. |
| CMCS | Black Soldier Fly (BSF) | $120–$345 / kg | $120/kg at 1-ton scale. Eco-preferred. |
| COS-HCl (Chitosan AG) | Mushroom / Insect | $66–$78 / kg | Tiered: 1–499 kg ($78), >1,000 kg ($66). Product page |
| COS-Lac (Chitosan FG) | Mushroom / Insect | $72–$84 / kg | Tiered: 1–499 kg ($84), >1,000 kg ($72). Product page |
Versión en Español – Pautas de Costos y AbastecimientoEl presupuesto para la escala industrial debe considerar el origen. El CMCS de hongos oscila entre $155-$254/kg, mientras que el derivado de insectos baja a $120/kg en pedidos de una tonelada. Las variantes COS (Clorhidrato y Lactato) son significativamente más económicas, oscilando entre $66 y $84/kg en volúmenes comerciales, lo que las hace financieramente viables para operaciones camaroneras a gran escala.
12. Combination Recommendations
The literature emphasizes that chitosan performs best as a synergistic delivery matrix rather than a standalone silver bullet. For the Ecuador pilot, three combinations are strongly recommended based on cited literature:
- CMCS + Pectin (The Barrier Approach): Based on PMC12014517, combining 1% CMCS with 2% pectin creates an exceptional oxygen barrier. This is highly suitable for premium whole-head shrimp exported on ice.
- COS + Hypotaurine (The Antioxidant Approach): Supported by e-FAS 2022, 1% chitosan plus 2% hypotaurine deeply suppresses total viable microbial counts and limits lipid oxidation (TBA < 0.6 mg MDA/kg).
- CMCS + Citric Acid + L-cysteine (The 100% Clean-Label Approach): Based on PMC6859178, the optimized formula of 1.36% chitosan, 0.47% citric acid, and 0.31% L-cysteine provides a complete replacement for sulfites and 4-HR without regulatory residue limits.
Versión en Español – Recomendaciones de CombinaciónLa literatura destaca que el quitosano funciona mejor como matriz sinérgica. Se recomiendan tres combinaciones: 1) CMCS + Pectina para una barrera física excepcional contra el oxígeno; 2) COS + Hipotaurina para una supresión antimicrobiana y antioxidante profunda; y 3) CMCS + Ácido Cítrico + L-cisteína como una alternativa 100% de etiqueta limpia, reemplazando totalmente a los sulfitos y al 4-HR sin límites de residuos regulatorios.
13. Conclusions
This pilot protocol provides a defensible, evidence-backed framework for transitioning the Ecuadorian shrimp industry away from controversial melanosis inhibitors. While traditional SMS and 4-HR remain potent, regulatory pressures demand alternatives. Carboxymethyl chitosan (CMCS) offers superior film-forming oxygen barriers, while low-molecular-weight chitosan oligosaccharide lactate (COS-Lac) provides an economical, highly soluble, food-grade antimicrobial matrix. Executing the 9-arm trial outlined above will allow producers to empirically validate the exact formulation that balances cost, regulatory compliance (especially for the EU market via non-crustacean sources), and a minimum 14-day shelf life extension.
Versión en Español – ConclusionesEste protocolo piloto proporciona un marco defendible y respaldado por evidencia para la transición de la industria camaronera ecuatoriana lejos de inhibidores de melanosis controversiales. Aunque el SMS y el 4-HR tradicionales siguen siendo potentes, las presiones regulatorias exigen alternativas. El quitosano carboximetilado (CMCS) ofrece barreras físicas superiores contra el oxígeno, mientras que el oligosacárido de quitosano lactato (COS-Lac) proporciona una matriz antimicrobiana económica, altamente soluble y de grado alimenticio. La ejecución del ensayo de 9 brazos permitirá a los productores validar empíricamente la formulación exacta que equilibre costos, cumplimiento regulatorio y una extensión de vida útil mínima de 14 días.
14. References / Referencias
- Ali, S., et al. (2026). “Chitosan-Based Active Packaging for Shrimp Preservation: Development, Functionalization, and Industrial Prospects.” Foods, 15(6), 1043. Available at: https://www.mdpi.com/2304-8158/15/6/1043
- Chen, M., et al. (2022). “Effect of chitosan coating combined with hypotaurine on the quality of shrimp (Litopenaeus vannamei) during chilled storage.” Fisheries and Aquatic Sciences. Available at: https://www.e-fas.org/archive/view_article?pid=fas-25-2-64
- Gumus, B., et al. (2023). “Chitosan Decelerates Melanosis in Shrimp: A Novel Technique for Visual Quality Assessment Using Digital Image Analysis.” International Journal of Agriculture. Available at: https://ija.scholasticahq.com/article/88509
- Huang, Z., et al. (2023). “Efficacy of Chitosan Oligosaccharide Combined with Cold Atmospheric Plasma for Controlling Quality Deterioration.” Foods, 12(9), 1763. Available at: https://www.mdpi.com/2304-8158/12/9/1763
- Qian, Y.F., et al. (2019/2020). “Formula optimization for melanosis-inhibitors of Pacific white shrimp.” Food Chemistry / PMC. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC6859178/
- Safari, R., et al. (2024). “Effects of Carboxymethyl Chitosan/Pectin Coating Containing Free and Nanoliposome Mentha piperita Essential Oil.” Food Science & Nutrition / PMC. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC12014517/
- Standard Operating Procedure Document: Melanosis Trial Information and Technical Profiles for Chitosan Oligosaccharide Application in Crustacean Post-Harvest (Internal Industry Document, 2026).
- Chitosan Global. (2025). Carboxymethyl Chitosan — Product Page. Available at: https://chitosanglobal.com/carboxymethyl-chitosan/
- Chitosan Global. (2025). Chitosan Oligosaccharide Hydrochloride (Chitosan AG) — Product Page. Available at: https://chitosanglobal.com/product/chitosan-oligosaccharide-hydrochloride-chitosan-ag/
- Chitosan Global. (2025). Chitosan Oligosaccharide Lactate / Chitosan FG — Product Page. Available at: https://chitosanglobal.com/product/chitonova-60-fg/
- Chitosan Global. (2025). Wholesale Pricing and Specifications. Available at: https://chitosanglobal.com/chitosan-wholesale-pricing/
- Kamali, M., et al. (2024). “Evaluating shelf life and anti-browning of shrimp by chitosan-coated nanoliposomes with licorice root extract.” Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC11215212/
- Zhang, H., et al. (2023). “Effect of chitosan-coated Ulva intestinalis sulfated polysaccharide on shrimp polyphenol oxidase activity.” International Journal of Biological Macromolecules. Available at: https://www.sciencedirect.com/science/article/abs/pii/S0141813023001514
- Zhou, X., et al. (2019). “Effects of chitosan-based coatings on storage quality of Chinese shrimp.” Food Science and Nutrition. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC6924340/